Real-time Estimate Cboe BZX 10:52:45 2024-04-25 am EDT 5-day change 1st Jan Change
3.37 USD -2.03% Intraday chart for Myomo, Inc. +19.50% -32.73%
Sales 2024 * 26.77M Sales 2025 * 35.2M Capitalization 98M
Net income 2024 * -7M Net income 2025 * -2M EV / Sales 2024 * 3.66 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 2.78 x
P/E ratio 2024 *
-16.1 x
P/E ratio 2025 *
-68.8 x
Employees 104
Yield 2024 *
-
Yield 2025 *
-
Free-Float 76.11%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.82%
1 week+26.47%
Current month+5.20%
1 month-3.64%
3 months-5.75%
6 months+207.14%
Current year-31.34%
More quotes
1 week
2.85
Extreme 2.85
3.64
1 month
2.51
Extreme 2.5108
3.64
Current year
2.51
Extreme 2.5108
5.17
1 year
0.37
Extreme 0.371
5.58
3 years
0.37
Extreme 0.369
14.35
5 years
0.37
Extreme 0.369
40.00
10 years
0.37
Extreme 0.369
695.89
More quotes
Managers TitleAgeSince
Chief Executive Officer 70 11-06-30
Director of Finance/CFO 62 19-02-17
Chief Tech/Sci/R&D Officer - 14-12-31
Members of the board TitleAgeSince
Chief Executive Officer 70 11-06-30
Director/Board Member 78 14-08-31
Director/Board Member 77 12-02-29
More insiders
Date Price Change Volume
24-04-25 3.37 -2.03% 22 614
24-04-24 3.44 -2.82% 76,789
24-04-23 3.54 +2.91% 100,483
24-04-22 3.44 +7.84% 215,473
24-04-19 3.19 +13.12% 324,053

Delayed Quote Nyse, April 24, 2024 at 04:00 pm EDT

More quotes
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm, and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. It provides devices directly to patients and bill their insurance companies directly. It also sells its products through various other sales channels, including through orthotics and prosthetics providers, the veteran’s administration, and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.44 USD
Average target price
6.312 USD
Spread / Average Target
+83.50%
Consensus